Records real-world results of a heat-based device used in brain surgery for movement disorders
Collects outcomes of radiofrequency ablation devices in people with Parkinson disease, dystonia, or tremor.
Plain-language title generated from the registry record
Registry title: Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System - RAPID for CNS
Key facts
- Where
- Cologne, Düsseldorf, and Würzburg, GermanySee the 3 sites
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people who are scheduled to have treatment with a commercially approved Boston Scientific radiofrequency (RF) ablation system for pain or for brain and nervous system conditions.
- Sex
- All sexes can join.
- Earlier treatment
- The person must be scheduled to be treated with a commercially approved Boston Scientific RF system, as set out in its local Directions for Use.
Main reasons for not taking part
- Has any contraindication listed in the local Directions for Use
- Has a cognitive impairment or another characteristic that limits the ability to assess pain relief
- Cannot complete the study assessments
Read by machine on 12 November 2026.
Where in Germany
- Uniklinik KölnCologne, GermanyContact: Boston Scientific Clinical ResearchTaking people
- Universitaetsklinikum DusseldorfDüsseldorf, GermanyContact: Boston Scientific Clinical ResearchTaking people
- Universitaetsklinikum WuerzburgWürzburg, GermanyContact: Boston Scientific Clinical ResearchTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Boston Scientific Corporation
- Trial code
- NCT06553625
- Record updated
- 13 October 2026
- Original description
The objective of this study is to compile real-world outcomes of Boston Scientific commercially approved radiofrequency (RF) ablation systems used in the central nervous system (CNS) for use in functional neurosurgery.Read full original descriptionShow less
Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System
The objective of this study is to compile real-world outcomes of Boston Scientific commercially approved radiofrequency (RF) ablation systems used in the central nervous system (CNS) for use in functional neurosurgery.
Inclusion: Study candidate is scheduled to be treated with a commercially approved Boston Scientific RF system for pain or for CNS applications per local Directions for Use (DFU); Signed a valid, IRB/EC/REB-approved informed consent form.
Exclusion: Currently diagnosed with cognitive impairment, or exhibits any characteristic, that would limit study candidate's ability to assess pain relief or to complete study assessments; Meets any contraindications per locally applicable Directions for Use (DFU).